Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Gillespie

Showing results (41-50 of 264) with videos related to

Pageof 27
Sort By:
Clinical Toxicology|July 1, 1981
Saline cathartics and saline cathartics plus activated charcoal as antidotal treatmentsL Chin, A L Picchioni, T Gillespie
Biopharmaceutics & Drug Disposition|March 1, 1993
Human dolasetron pharmacokinetics: II. Absorption and disposition following single-dose oral administration to normal male subjectsH Boxenbaum, T Gillespie, K Heck, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 12, 1998
Olanzapine 10-N-glucuronide. A tertiary N-glucuronide unique to humansK Kassahun, E Mattiuz, R Franklin, et al.
The Journal of Chemical Physics|August 20, 2005
Avoiding negative populations in explicit Poisson tau-leapingYang Cao, Daniel T Gillespie, Linda R Petzold
The Journal of Chemical Physics|January 11, 2005
The slow-scale stochastic simulation algorithmYang Cao, Daniel T Gillespie, Linda R Petzold
The Journal of Chemical Physics|February 8, 2006
Efficient step size selection for the tau-leaping simulation methodYang Cao, Daniel T Gillespie, Linda R Petzold
Bone|February 22, 2002
Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritisE Romas, M T Gillespie, T J Martin
The Journal of Chemical Physics|January 26, 2007
Effect of reactant size on discrete stochastic chemical kineticsDan T Gillespie, Sotiria Lampoudi, Linda R Petzold
The Journal of Chemical Physics|December 22, 2014
The small-voxel tracking algorithm for simulating chemical reactions among diffusing moleculesDaniel T Gillespie, Effrosyni Seitaridou, Carol A Gillespie
Biopharmaceutics & Drug Disposition|December 1, 1992
Human dolasetron pharmacokinetics: I. Disposition following single-dose intravenous administration to normal male subjectsH Boxenbaum, T Gillespie, K Heck, et al.
Pageof 27

Showing results (41-50 of 264) with videos related to

Sort By:
Pageof 27
Clinical Toxicology|July 1, 1981
Saline cathartics and saline cathartics plus activated charcoal as antidotal treatmentsL Chin, A L Picchioni, T Gillespie
Biopharmaceutics & Drug Disposition|March 1, 1993
Human dolasetron pharmacokinetics: II. Absorption and disposition following single-dose oral administration to normal male subjectsH Boxenbaum, T Gillespie, K Heck, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 12, 1998
Olanzapine 10-N-glucuronide. A tertiary N-glucuronide unique to humansK Kassahun, E Mattiuz, R Franklin, et al.
The Journal of Chemical Physics|August 20, 2005
Avoiding negative populations in explicit Poisson tau-leapingYang Cao, Daniel T Gillespie, Linda R Petzold
The Journal of Chemical Physics|January 11, 2005
The slow-scale stochastic simulation algorithmYang Cao, Daniel T Gillespie, Linda R Petzold
The Journal of Chemical Physics|February 8, 2006
Efficient step size selection for the tau-leaping simulation methodYang Cao, Daniel T Gillespie, Linda R Petzold
Bone|February 22, 2002
Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritisE Romas, M T Gillespie, T J Martin
The Journal of Chemical Physics|January 26, 2007
Effect of reactant size on discrete stochastic chemical kineticsDan T Gillespie, Sotiria Lampoudi, Linda R Petzold
The Journal of Chemical Physics|December 22, 2014
The small-voxel tracking algorithm for simulating chemical reactions among diffusing moleculesDaniel T Gillespie, Effrosyni Seitaridou, Carol A Gillespie
Biopharmaceutics & Drug Disposition|December 1, 1992
Human dolasetron pharmacokinetics: I. Disposition following single-dose intravenous administration to normal male subjectsH Boxenbaum, T Gillespie, K Heck, et al.
Pageof 27